Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03075553
Title Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Mayo Clinic
Indications

mycosis fungoides

peripheral T-cell lymphoma

anaplastic large cell lymphoma

adult T-cell leukemia

mature T-cell and NK-cell lymphoma

Therapies

Nivolumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST